<DOC>
	<DOCNO>NCT00002997</DOCNO>
	<brief_summary>RATIONALE : Cryosurgery liver metastasis may fewer side effect improve recovery . PURPOSE : Phase II trial study effectiveness cryosurgery patient unresectable liver metastasis colorectal cancer .</brief_summary>
	<brief_title>Cryosurgery Treating Patients With Unresectable Liver Metastases From Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate feasibility conduct multi-institutional clinical study cryosurgery liver metastasis . II . Evaluate morbidity mortality cryosurgery liver metastasis apply multi-institutional setting . III . Evaluate efficacy cryosurgery liver metastasis measure total liver control , local lesion control , overall survival . OUTLINE : This multi-institutional study . Patients first confirm exploratory laparotomy extrahepatic metastasis . They undergo biopsy portal lymph node , , full mobilization liver recommend . Cholecystectomy optional recommend treatment tumor adjacent gallbladder . After map location size metastatic tumor ultrasound , cryoablation metastasis carry . Cryoablation involve delivery nitrogen metallic probe place surgically center liver metastasis . There two freeze thaw cycle lesion synchronous intraoperative ultrasound monitoring cryoablation . One centimeter margin cryoablation determine ultrasound image . Treatment liver regional chemotherapy allow radiographic pathologic confirmation disease progression liver . Follow-up 3 week surgery every 3 month . PROJECTED ACCRUAL : There maximum 45 patient accrue approximately 3 year study . This two stage accrual design 17 patient first accrue 15 eligible . If few 11 initial 15 eligible patient show evidence disease 3 month , study stop treatment abandon . If least 11 patient show evidence disease , 28 additional patient accrue .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm primary colorectal adenocarcinoma synchronous metachronous metastasis liver 1 5 liver metastasis demonstrate rapid sequence CT scan Feridexenhanced MRI within 2 week registration CT portography require No single metastasis great 6 cm Maximum liver involvement must 40 % volume No extrahepatic metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Hematopoietic : Platelet count great 80,000/mm3 Prothrombin time le 15.0 second Hepatic : Bilirubin le 2.0 mg/dL Renal : Not specify Other : Must disease free least 5 year except treat basal cell squamous cell skin cancer PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Prior chemotherapy allow No concurrent regional chemotherapy allow Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2004</verification_date>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
	<keyword>liver metastasis</keyword>
</DOC>